日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study

维生素、抗生素、益生菌和新冠肺炎病史对溃疡性结肠炎患者肠道菌群的影响:一项横断面研究

Straume, Zane; Krūmiņa, Nikola; Elbere, Ilze; Rozenberga, Maija; Erts, Renārs; Rudzīte, Dace; Proskurina, Anna; Krumina, Angelika

Tracking the origin of bacterial DNA in blood: Indication of localized and sporadic transfer from other body sites

追踪血液中细菌DNA的来源:提示可能存在来自其他身体部位的局部和散发性转移

Rozenberga, Maija; Saksis, Rihards; Elbere, Ilze; Birzniece, Liga; Briviba, Monta; Konrade, Ilze; Klovins, Janis

Dual-approach analysis of gut microbiome in patients with type 1 diabetes and diabetic kidney disease

对1型糖尿病合并糖尿病肾病患者肠道微生物组进行双重分析

Bunka, Laura; Rozenberga, Maija; Silamiķelis, Ivars; Saksis, Rihards; Birzniece, Līga; Megnis, Kaspars; Fedulovs, Aleksejs; Pahirko, Leonora; Zaļizko, Poļina; Krustiņš, Eduards; Kloviņš, Jānis; Sokolovska, Jeļizaveta; Elbere, Ilze

Gut microbiome encoded purine and amino acid pathways present prospective biomarkers for predicting metformin therapy efficacy in newly diagnosed T2D patients

肠道微生物组编码的嘌呤和氨基酸代谢通路是预测新诊断的2型糖尿病患者二甲双胍治疗疗效的潜在生物标志物。

Elbere, Ilze; Orlovskis, Zigmunds; Ansone, Laura; Silamikelis, Ivars; Jagare, Lauma; Birzniece, Liga; Megnis, Kaspars; Leskovskis, Kristaps; Vaska, Annija; Turks, Maris; Klavins, Kristaps; Pirags, Valdis; Briviba, Monta; Klovins, Janis

Evaluating the Efficacy of Type 2 Diabetes Polygenic Risk Scores in an Independent European Population

在独立的欧洲人群中评估2型糖尿病多基因风险评分的有效性

Brīvība, Monta; Atava, Ivanna; Pečulis, Raitis; Elbere, Ilze; Ansone, Laura; Rozenberga, Maija; Silamiķelis, Ivars; Kloviņš, Jānis

Gut Microbiome Composition and Dynamics in Hospitalized COVID-19 Patients and Patients with Post-Acute COVID-19 Syndrome

新冠肺炎住院患者和新冠肺炎后急性期患者肠道微生物群组成及动态变化

Brīvība, Monta; Silamiķele, Laila; Birzniece, Līga; Ansone, Laura; Megnis, Kaspars; Silamiķelis, Ivars; Pelcmane, Līva; Borisova, Daniella; Rozenberga, Maija; Jagare, Lauma; Elbere, Ilze; Kloviņš, Jānis

Changes in the type 2 diabetes gut mycobiome associate with metformin treatment across populations

2型糖尿病肠道菌群的变化与二甲双胍治疗在不同人群中均存在关联

Van Syoc, Emily; Nixon, Michelle Pistner; Silverman, Justin D; Luo, Yuhong; Gonzalez, Frank J; Elbere, Ilze; Klovins, Janis; Patterson, Andrew D; Rogers, Connie J; Ganda, Erika

Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance

二甲双胍靶向高脂饮食诱发的肥胖和胰岛素抵抗小鼠模型中的肠道免疫系统信号通路

Monta Brīvība, Laila Silamiķele, Ineta Kalniņa, Ivars Silamiķelis, Līga Birzniece, Laura Ansone, Lauma Jagare, Ilze Elbere, Jānis Kloviņš

Changes in the Type 2 diabetes gut mycobiome associate with metformin treatment across populations

2型糖尿病肠道菌群的变化与二甲双胍治疗在不同人群中均存在关联

Van Syoc, Emily; Nixon, Michelle Pistner; Silverman, Justin D; Luo, Yuhong; Gonzalez, Frank J; Elbere, Ilze; Klovins, Janis; Patterson, Andrew D; Rogers, Connie J; Ganda, Erika

Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes

二甲双胍对高脂饮食诱导的2型糖尿病小鼠模型(雌雄均适用)的肠道微生物群组成有显著影响

Silamiķele, Laila; Silamiķelis, Ivars; Ustinova, Monta; Kalniņa, Zane; Elbere, Ilze; Petrovska, Ramona; Kalniņa, Ineta; Kloviņš, Jānis